Connecting with people who have the same challenges as you can teach you new ways to cope. This kind of support may also help you stay on track with your treatment.
Use the tool below to find a local chapter of the Depression and Bipolar Support Alliance (DBSA). DBSA provides hope, help, support, and education to improve the lives of people who have mood disorders. DBSA chapters offer peer-run support groups across the nation.
DBSA provides hope, help, support, and education to improve the lives of people who have mood disorders. DBSA Chapters offer peer-run support groups across the nation. Find a local DBSA chapter using the search tool above.
NAMI is the nation’s largest grassroots mental health organization dedicated to building better lives for the millions of Americans affected by mental illness. With more than 600 local Affiliates and 49 State Organizations, NAMI works to educate, support, advocate, listen and lead. For over 40 years, NAMI has been a beacon of help and hope, fighting for more research, better education, bolder advocacy and broader public awareness.
This is My Brave, Inc. uses the power of storytelling to break down stigma surrounding mental health and addiction. This Is My Brave hosts events across the country where stories are performed by individuals living with - or loving someone with - mental health conditions and/or addiction. This Is My Brave believes #StorySavesLives.
AFSP is the leader in the fight against suicide. ASFP funds research, creates educational programs, advocates for public policy, and supports survivors of suicide loss.
MHA is the nation’s leading community-based nonprofit dedicated to helping all Americans achieve wellness by living mentally healthier lives.
The mission of NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure.
MentalHealth.gov provides one-stop access to U.S. government mental health and mental health problems information.
AbbVie does not review or control the content of these websites.
This list does not constitute an endorsement by AbbVie.
*AbbVie is a sponsor of these organizations.
INDICATIONS AND USAGE
VRAYLAR is approved in adults to treat depressive episodes that happen with bipolar I disorder (bipolar depression) and for the short-term (acute) treatment of manic or mixed episodes that happen with bipolar I disorder.
IMPORTANT SAFETY INFORMATION
Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis.
VRAYLAR and antidepressants may increase suicidal thoughts or actions in some children and young adults especially within the first few months of treatment or when the dose is changed. Depression and other mental illnesses are the most important causes of suicidal thoughts and actions. Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when VRAYLAR or the antidepressant is started or when the dose is changed. Report any change in these symptoms immediately to the doctor.
VRAYLAR may cause serious side effects, including:
Who should not take VRAYLAR?
Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat).
What should I tell my healthcare provider before taking VRAYLAR?
Tell your healthcare provider about any medical conditions and if you:
Tell your healthcare provider about all medicines that you take, including prescriptions, over-the-counter medicines, vitamins, and supplements. VRAYLAR may affect the way other medicines work, and other medicines may affect how VRAYLAR works. Do not start or stop any medicines while taking VRAYLAR without talking to your healthcare provider.
What are the most common side effects of VRAYLAR?
The most common side effects include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness.
These are not all the possible side effects of VRAYLAR.
INDICATIONS AND USAGE
VRAYLAR is a prescription medicine used in adults:
Please see the full Prescribing Information, including Boxed Warnings, and Medication Guide.
US-VRAA-230239
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
*AbbVie is a sponsor of these organizations.
US-VRAA-220054
US-VRAA-220054
US-VRAA-220054
US-VRAA-220054